The association between diabetes, insulin use, and colorectal cancer among Whites and African Americans

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 4, 2009, Pages 1239-1242

  Vinikoor, Lisa C ^a,b   Long, Millie D ^b   Keku, Temitope O ^b   Martin, Christopher F ^b   Galanko, Joseph A ^b   Sandler, Robert S ^b  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER RISK; CAUCASIAN; COLON CANCER; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN TREATMENT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RECTUM CANCER; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

AFRICAN AMERICANS; AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; NORTH CAROLINA; ODDS RATIO; RISK FACTORS;

EID: 66649123132     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-1031     Document Type: Article

References (14)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005;97:1679-1687 (Pubitemid 41672234)
3. Yang YX, Hennessy S, Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 2004;127:1044-1050 (Pubitemid 39345873)
4. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001;131:3109-20S.
5. Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 2001;94:972-980
6. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000;92:1472-1489
7. Watson AJ. An overview of apoptosis and the prevention of colorectal cancer. Crit Rev Oncol Hematol 2006;57:107-121 (Pubitemid 43139699)
8. Keku TO, Lund PK, Galanko J, Simmons JG, Woosley JT, Sandler RS. Insulin resistance, apoptosis, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2005;14:2076-2081 (Pubitemid 41603248)
9. Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006;98:920-931 (Pubitemid 44018922)
10. Friedenreich C, Norat T, Steindorf K, et al. Physical activity and risk of colon and rectal cancers: the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2006;15:2398-2407 (Pubitemid 46048296)
11. Govindarajan R, Ratnasinghe L, Simmons DL, et al. Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. J Clin Oncol 2007;25:1476-1481 (Pubitemid 46733074)
12. Long MD, Vinikoor LC, Martin CF, Keku TO, Galanko JA, Sandler RS. Thiazolidinedione use and rectal cancer in diabetics: a population based case-control study. Submitted for publication, 2008.
13. Wacholder S, Weinberg CR. Flexible maximum likelihood methods for assessing joint effects in case-control studies with complex sampling. Biometrics 1994;50:350-357 (Pubitemid 24230615)
14. Weinberg CR, Sandler DP. Randomized recruitment in case-control studies. Am J Epidemiol 1991;134:421-432